Cargando…

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy

Tumor vaccines have been used to treat cancer. How to efficiently induce tumor-associated antigens (TAAs) secretion with host immune system activation is a key issue in achieving high antitumor immunity. Immunogenic cell death (ICD) is a process in which tumor cells upon an external stimulus change...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yichen, Ma, Rong, Zhang, Mengzhe, Cao, Yongjian, Zhang, Zhenzhong, Yang, Weijing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534761/ https://www.ncbi.nlm.nih.gov/pubmed/37766117 http://dx.doi.org/10.3390/vaccines11091440

Ejemplares similares

Transformable prodrug nanoplatform via tumor microenvironment modulation and immune checkpoint blockade potentiates immunogenic cell death mediated cancer immunotherapy
por: Yang, Weijing, et al.
Publicado: (2023)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Zhang, Peisen, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

RNA Nanotechnology-Mediated Cancer Immunotherapy
por: Lin, Yao-Xin, et al.
Publicado: (2020)

Nanotechnology-based products for cancer immunotherapy
por: Shams, Forough, et al.
Publicado: (2021)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
por: Tang, Lin, et al.
Publicado: (2022)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
por: Liu, Zhaoyuan, et al.
Publicado: (2021)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
por: Cruickshank, Brianne, et al.
Publicado: (2018)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2020)

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
por: Bockamp, Ernesto, et al.
Publicado: (2020)

Current applications and future prospects of nanotechnology in cancer immunotherapy
por: Yan, Sen, et al.
Publicado: (2019)

Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy
por: Goracci, Martina, et al.
Publicado: (2020)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
por: Koyande, Navami Prabhakar, et al.
Publicado: (2022)

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
por: Ma, Xiaohong, et al.
Publicado: (2023)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
por: Gao, Jing, et al.
Publicado: (2020)

DNA nanotechnology assisted nanopore-based analysis
por: Ding, Taoli, et al.
Publicado: (2020)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
por: Ma, Jing, et al.
Publicado: (2020)

Nanotechnology-Assisted Cell Tracking
por: Peserico, Alessia, et al.
Publicado: (2022)

Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
por: Li, Yang, et al.
Publicado: (2021)

Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020)

Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2021)

When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
por: Yu, Linna, et al.
Publicado: (2022)

A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers
por: Akkın, Safiye, et al.
Publicado: (2021)

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
por: Lu, Jianqin, et al.
Publicado: (2017)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

Revolutionizing cancer treatment: nanotechnology-enabled photodynamic therapy and immunotherapy with advanced photosensitizers
por: Jia, Jiedong, et al.
Publicado: (2023)

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
por: Liao, Xinghe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ntcm95su4n5lqi039qam7tg1l